Category Archives: Biotech

CDI

CDI, Nanion Form Agreement

Celluar Dynamics International (CDI) and Nanion Technologies, a leading provider of instrumentation for ion channel drug discovery and screening, announced they have entered into a joint marketing agreement. According to a…

Cellectar

Cellectar, Onconova Therapeutics Collaborate

Cellectar Biosciences announced today it has entered into a strategic collaboration with Onconova Therapeutics, a biopharmaceutical company, to develop new phospholipid drug conjugates (PDC). According to a release, the Newtown,…

Gregor Diagnostics

Gregor Diagnostics to License Biomarkers

Gregor Diagnostics announced today a licensing agreement for intellectual property with the Wisconsin Alumni Research Foundation. According to a release, the molecular diagnostics company will have exclusive rights to biomarkers that…

Stemina

Stemina Prepares for Commercialization

Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently. According to a release, Heiner Dreismann, the former head…

JangoBio

JangoBio Adding Staff, Expanding Testing Capabilities

Story provided by Alex Moe, WisBusiness.com A Madison-based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment. JangoBio is trying to develop…

Propeller Health

Propeller, GSK Expand Collaboration

Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK…

Cellectar

Cellectar’s Platform Shows Therapeutic Potential

Cellectar Biosciences‘ Phospholipid Drug Conjugate (PDC) research program has generated numerous PDC molecules that show “significant” improved pharmacologic activity, the company announced today. According to a release, Cellectar’s research demonstrates that…

Cellectar

Cellectar Provides Myeloma Study Update

Cellectar Biosciences’ CLR 131 has achieved an overall survival of greater than 22 months in advanced multiple myeloma patients, the company announced today. “We continue to make meaningful progress on…

SHINE Medical

SHINE Breaks Ground in Janesville

SHINE Medical Technologies broke ground today on Building One, its nuclear technology facility in Janesville, Wis. The 11,500-square-foot facility, located east of Southern Wisconsin Regional Airport, will house a prototype to…

MVI logo

MVI Provides Trial Update

In its clinical trial to treat prostate cancer, Madison Vaccines Incorporated (MVI) announced today it has begun dosing 20 patients. According to a release, MVI is exploring the use of its gene…